Brief: Cullinan Oncology Provides Corporate Update And Reports Third Quarter 2023 Financial Results

Cullinan Therapeutics

08/11/2023 12:24

Nov 8 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS
THIRD
QUARTER 2023 FINANCIAL RESULTS
    * CASH AND INVESTMENT POSITION OF $482 MILLION AS OF
SEPTEMBER 30,
2023 EXPECTED TO PROVIDE RUNWAY INTO SECOND HALF OF 2026
    * EXPECT TO PRESENT DATA FOR CLN-049 AND CLN-418 IN SECOND
HALF OF
2024
    * QTRLY LOSS PER SHARE $0.91
    * Q3 EARNINGS PER SHARE VIEW $-0.92 -- LSEG IBES DATA

Source text for Eikon:  ID:nGNXbzpWyl 
Further company coverage:  CGEM.O 

 ((Reuters.Briefs@thomsonreuters.com;))